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Background: Reduction in the number of circulating blood lymphocytes (lymphocytopaenia) has been reported
during clinical episodes of malaria and is normalized after treatment with anti-malaria drugs. While this phenomenon is
well established in malaria infection, the underlying mechanisms are still not fully elucidated. In the present study, the
occurrence of apoptosis and its pathways in CD4+ T cells was investigated in naturally Plasmodium vivax-infected
individuals from a Brazilian endemic area (Porto Velho – RO).
Methods: Blood samples were collected from P. vivax-infected individuals and healthy donors. The apoptosis was
characterized by cell staining with Annexin V/FITC and propidium iodide and the apoptosis-associated gene expression
profile was carried out using RT2 Profiler PCR Array–Human Apoptosis. The plasma TNF level was determined by ELISA.
The unpaired t-test or Mann–Whitney test was applied according to the data distribution.
Results: Plasmodium vivax-infected individuals present low number of leukocytes and lymphocytes with a higher
percentage of CD4+ T cells in early and/or late apoptosis. Increased gene expression was observed for TNFRSF1B
and Bid, associated with a reduction of Bcl-2, in individuals with P. vivax malaria. Furthermore, these individuals
showed increased plasma levels of TNF compared to malaria-naive donors.
Conclusions: The results of the present study suggest that P. vivax infection induces apoptosis of CD4+ T cells
mediated by two types of signaling: by activation of the TNFR1 death receptor (extrinsic pathway), which is amplified by
Bid, and by decreased expression of the anti-apoptotic protein Bcl-2 (intrinsic pathway). The T lymphocytes apoptosis
could reflect a strategy of immune evasion triggered by the parasite, enabling their persistence but also limiting the
occurrence of immunopathology.
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Malaria infection induces significant changes in the
haematological parameters of the host. A decrease in the
number of circulating blood lymphocytes (lymphocyto-
paenia) is a well-documented phenomenon in naturally
infected individuals during acute Plasmodium falcip-
arum [1-6] and Plasmodium vivax [5,7-9].* Correspondence: lilacerdabueno@gmail.com
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unless otherwise stated.Specific T cell depletion has been observed during in-
fection with different species of Plasmodium (Plasmo-
dium chabaudi, Plasmodium vinckei and Plasmodium
yoelii YM) [10]. In human and experimental models of
malaria, lymphocytopaenia has been attributed to the
apoptosis of T lymphocytes and has been associated with
high plasma levels of sIL-2R (soluble IL-2 receptor)
[7,11,12] or the Fas/FasL system [4,7,13]; however, the
mechanisms of apoptosis during malaria, particularly
during P. vivax infection, is not fully elucidated. On the
other hand, some studies have suggested that lymphocy-
topaenia during infection is caused by the reallocation oftral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ance of these cells in the blood during the treatment
[3,14,15].
Considering the importance of CD4+ T cells in the
protective immune response in vivax malaria, the object-
ive of the present study was to verify possible mecha-
nisms involved in lymphocytopaenia.Methods
Study population
This study was performed with blood samples collected
from 20 subjects naturally infected with Plasmodium
vivax (P. vivax-infected donors) with uncomplicated
symptomatic malaria, recruited at the Research Centre
in Tropical Medicine (Porto Velho, Rondônia–Brazil), a
malaria-endemic area. The control group consisted of 11
healthy donors (malaria-naive donors) from a non-
endemic area (Belo Horizonte, Minas Gerais–Brazil)
(Table 1). Parasitaemia was determined by well-trained
microscopists from the Research Centre in Tropical
Medicine. Plasmodium vivax mono-infection was con-
firmed by PCR, as previously described [16]. Haemato-
logical parameters were measured using an automated
blood cell counter (ABX Pentra 90; Horiba Diagnostics,
Kyoto, Japan) (Table 1). HIV, dengue and hepatitis test-
ing was performed in all samples in order to exclude
coinfections or comorbidities.Ethics statement
This study was approved by the Ethics Committee of








Haemoglobin (g/dL) 14.05 ± 0.35
Haematocrit 41.27 ± 0.90
RBCs (cells/mm3) 4741000 ± 109300
WBCs (cells/mm3) 8118 ± 517.30
Lymphocytes (cells/mm3) 2650 ± 221.5
Monocytes (cells/mm3) 177.1 ± 16.18
Granulocytes 5270 ± 396.7
Eosinophils (cells/mm3) 179.5 ± 18.31
Platelets (cells/mm3) 246500 ± 21290
*Statistical differences determined by unpaired t-test.0008.0.046.000-11, 0449.0.203.000-09), and written in-
formed consent was obtained from all participants.Blood samples
Peripheral venous blood was collected in tubes containing
EDTA and heparin. The blood collected with EDTA was
used to confirm the diagnosis (P. vivax mono-infection)
by PCR, to determine parasitaemia by microscopy (thick
smears), to evaluate the haematological parameters and
for cell phenotyping. Heparinized blood was used to ob-
tain plasma for the cytokine assay and to obtain peripheral
blood mononuclear cells (PBMCs) for the isolation of
CD4+ T cells used to evaluate the apoptosis-associated
gene expression profiles.Cell phenotyping
The apoptotic profile of the CD4+ lymphocyte popula-
tion from both groups was characterized by Annexin
V/FITC and propidium iodide (PI) cell staining (BD
Biosciences, USA) using fresh whole blood. Briefly, the eryth-
rocytes were lysed with ammonium chloride (150 mM) and
washed twice in PBS. The cells were then stained with
PerCP-conjugated monoclonal antibodies specific for CD4
(clone L200) (Becton Dickinson, USA) for 30 minutes
in the dark at room temperature and later stained with
Annexin V/FITC and PI. Phenotypic analyses were
performed by flow cytometry with a FACScan flow
cytometer (BD Biosciences, USA). Data were collected
on 1x105 lymphocytes (gated by forward and side scat-
ter) and analysed using Flow Jo software (Tree Star
Inc., USA).ia-naive donors and P. vivax-infected donors (Mean ± SD)






13.52 ± 0.29 0.263
38.47 ± 0.78 0.028
4724000 ± 78940 0.901
5475 ± 358.1 <0.001
1511 ± 122.5 <0.0001
351.4 ± 34.49 0.001
3686 ± 258.0 0.002
121.4 ± 9.91 0.006
124100 ± 13470 <0.0001
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Blood samples from eight P.vivax-infected donors and
three malaria-naive donors were used to evaluate the pos-
sible pathways involved in CD4+ T cells apoptosis. PBMCs
were obtained from heparinized blood samples using a
Ficoll density gradient centrifugation method (Histopaque,
Sigma, USA). The blood sample was added gently above
the Histopaque solution and then was centrifuged at 400 g
for 40 minutes. Next, the phase containing the PBMCs
was transferred to another tube, and the cells were washed
twice with RPMI 1640 medium supplemented with 1%
antibiotic (Gibco) and centrifuged at 400 g for 10 minutes.
CD4+ T cells were isolated from PBMCs using a positive
selection based by direct magnetic labelling using CD4
microBeads (Miltenyi Biotec, USA) following the manu-
facturer’s instructions. The enriched CD4+ T cells were re-
suspended in TRIzol Reagent (Life Technologies) and
stored at – 80°C until further use. Cells were submitted to
subsequent RNA isolation, which was performed follow-
ing manufacturer’s instructions (Life Technologies, USA).
The total RNA was treated with DNAse (Promega) and
was then converted into cDNA using High-Capacity
cDNA Reverse Transcription (Applied Biosystems) follow-
ing the manufacturer’s instructions. PCR using primers
for the human GAPDH gene was performed to confirm
the cDNA synthesis.
The evaluation of apoptosis-associated gene expression
profiles was carried out using RT2 Profiler PCR Array–
Human Apoptosis (SABioscience), which determines 84
genes involved in different apoptosis pathways. The
qPCR was performed using 30 ng of cDNA per well in
an ABI7500 Real Time PCR System (Applied Biosystem,
USA). The obtained data were analysed using the ΔΔCT
method.
Cytokine assay
The plasma TNF level was determined by enzyme-linked
immunosorbent assay (ELISA) (R&D Systems) according
to the manufacturer’s instructions. Biotin-labeled anti-
bodies were used for detection, then revealed with
streptavidin-HRP (Amersham Biosciences, USA) and the
OPD substrate system (Sigma). The colorimetric reac-
tion was read in an automated ELISA microplate reader
at 492 nm. The cytokine concentration was calculated
from the standard curve using seven-parameter curve
fitting software (SOFTmaxH Pro 5.3, Molecular Devices,
USA), and the results were expressed in pg/mL. The
limit of detection for the assay was 15.6 pg/mL.
Statistical analysis
Statistical analyses were carried out using Prism soft-
ware 5.0 for Windows. Initially, the Kolmogorov-Smirnoff
test was applied to verify whether the obtained data repre-
sent a normal distribution. The unpaired t-test orMann–Whitney test was applied according to the data
distribution. Grubb’s test was also used to verify out-
liers. A P-value < 0.05 was considered significant.
Results
Plasmodium vivax infection leads to leukopaenia,
lymphocytopaenia and other haematological alterations
Previous reports have shown that malaria infection leads
to alterations in haematological parameters during acute
clinical episodes [5,7-9]. Consistent with these data, the
analysis of haematological parameters revealed that P.
vivax-infected donors had a significant reduction in the
number of leukocytes (p = 0.0002) and lymphocytes (p <
0.0001) compared with malaria-naive donors. Reductions
in granulocytes (p = 0.002), eosinophils (p = 0.006), plate-
lets (p < 0.0001) and haematocrit (p = 0.028), as well as
an increase in monocytes (p = 0.001), were also observed
(Table 1).
Plasmodium vivax infection induces apoptosis of CD4+ T
cells
To determine whether the reduction in the number of
lymphocytes was due to apoptosis of CD4+ T cells, whole
blood samples of both P. vivax-infected donors and
malaria-naive donors were stained with Annexin-V, PI and
anti-CD4 antibody (Figure 1A). The results showed an in-
crease in the percentage of CD4+ T cells in early apoptosis
(Annexin V+) in P. vivax-infected donors (3.11%)
compared to malaria-naive donors (0.34%) (p < 0.0001,
Figure 1B). Analysis of CD4+ T cells also demonstrated
that P. vivax-infected donors had a higher percentage of
circulating cells in late apoptosis (Annexin V+/PI+)
(14.86%) compared to malaria-naive donors (1.29%) (p <
0.0001, Figure 1C). Flow cytometric analysis of non-CD4
T cells and monocytes demonstrated a significant increase
in the percentage of cells in early apoptosis (Annexin V+)
in P. vivax-infected donors (2.03% and 1.93%, respectively)
compared to malaria-naive donors (0.99% and 0.14%, re-
spectively) (p < 0.0001 for both, see Additional file 1). No
differences were observed in the frequency of non-CD4 T
cells and monocytes in late apoptosis for P. vivax infected
individuals (0.50% and 0.72%, respectively) when com-
pared to malaria-naive donors (0.27% and 0.41%, respect-
ively). On the other hand, further analysis focusing in
granulocytes demonstrated a significant decrease of fre-
quency of cells in late apoptosis in P. vivax-infected do-
nors (1.99%) compared to malaria-naive donors (7.85%)
(p = 0.0009 for both, see Additional file 1).
Gene expression profiles indicate that P. vivax infection
induces apoptosis in T CD4+ cells by both extrinsic and
intrinsic pathways
The observation that P. vivax infection induces apop-
tosis in CD4+ T cells prompted us to examine the
Figure 1 Flow cytometric analysis of apoptosis. Representative example of gating strategy used to characterize CD4+ T cells in apoptosis,
using co-staining with Annexin-V and PI (A). Percentage of CD4+ T cells in early (B) and late (C) apoptosis from malaria-naive donors (n = 11) and
P. vivax-infected donors (n = 20). An unpaired t-test was used for comparison and the results were expressed as the mean ± SEM.
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CD4+ T cells (average 99.5%, see Additional file 2) were
evaluated for apoptosis-associated gene expression profiles
(Figure 2A).
Analysis of 84 genes involved in different pathways of
apoptosis showed differential expression of 10 genes in P.Figure 2 Gene expression profiles associated with apoptosis pathways.
gene expression was evaluated in malaria-naive donors (n = 3) and P. vivax-in
they were involved in: extrinsic pathway (B), intrinsic pathway (C) and apopto
from P. vivax-infected individuals in relation to the control group (malaria-naiv
performed using PCR Array Data Analysis Web Portal (SABiosciences). *p < 0.0vivax-infected patients in comparison to malaria-naive do-
nors. These genes were separated into three groups based
on extrinsic or intrinsic pathways and apoptosis inhibitors
(Figure 2B, C and D, respectively). A significant increase
was observed in the gene expression of TNFRSF1B (3.40;
p = 0.026), an important death receptor expressed on theRepresentative example of amplification plot (A). Apoptosis-associated
fected donors (n = 8). Genes were grouped according to the pathway
sis inhibitors (D). Bars represent fold regulation of genes in CD4+ T cells
e donors) with statistically significant results. Statistical analyses were
5, **p < 0.01, ***p < 0.0001.
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teracts with the CD40 receptor, and TNFRSF25, both of
which are expressed on the cell surface, were down-
regulated (p < 0.0001 and p = 0.028, respectively). Consid-
ering that the Bcl-2 family contains pro and anti-apoptotic
members, different levels of expression (up- and down-
regulation) were observed. While Bid expression was in-
creased 5-fold in P. vivax-infected individuals (p = 0.005),
Bcl-2 was 10-fold less expressed (p < 0.0001) in the same
donors. The genes involved in PIDDosome pathway (tp53
and caspase-2) were significantly down-regulated in P.
vivax malaria (p = 0.042 and p = 0.030; respectively). Some
genes encoding inhibitors of apoptotic proteins (IAPs),
also called Baculoviral inhibitors of apoptosis repeat con-
taining (Birc), were also down-regulated.
Plasma levels of TNF are higher in P. vivax-infected
donors
After observing a higher expression of TNFRSF1 in indi-
viduals infected with P. vivax, the plasma levels of
tumour necrosis factor (TNF) was determined. The re-
sults indicate that P. vivax-infected individuals had
higher levels of plasma TNF compared to malaria-naive
donors (p < 0.001, Figure 3), suggesting that P. vivax-in-
fected individuals have more probability in activating the
apoptosis cascade.
Discussion
A better understanding in the apoptosis mechanisms in-
duced by the P. vivax may be important to clarify the
modulation of the human immune response. During vivax
malaria, apoptosis is moslty found in CD4+ T cells with a
minor contribution of monocytes and non-CD4 T cells,
which present significant frequency of cells in early apop-
tosis. These data suggest that the leukopaenia andFigure 3 Plasma level of TNF. Levels of circulating TNF were
determined by ELISA in malaria-naive donors (n = 11) and P. vivax-
infected donors (n = 20). Mann–Whitney test was used for comparison
and the result was expressed as the median with interquartile range.lymphocytopaenia observed in P. vivax-infected individ-
uals is associated to apoptosis of CD4+ T cells. Moreover,
P. vivax-infected individuals had higher levels of plasma
TNF and increased gene expression of TNFRSF1B (death
receptor) and Bid (proapoptotic protein), and decreased
gene expression of Bcl-2 (anti-apoptotic protein).
Apoptosis is a cell death process tightly regulated that
may be triggered by different stimuli. Extrinsic stimuli
(TNF, FasL, TRAIL) can activate the apoptosis cascade
through death receptor expressed on the cell surface, such
as TNFR, Fas and TRAIL-R (extrinsic pathway) [17].
On the other hand, apoptosis can also be activated by
intrinsic stimuli caused by oxidative stress, leading to
alterations on mitochondrial membrane (intrinsic path-
way) [18]. The activation of intrinsic pathway initiated
by permeabilization of the outer mitochondrial mem-
brane provoked by pro-apoptotic proteins members of
Bcl family followed by the release of pro-apoptotic fac-
tors (cytochrome C, Smac/DIABLO, AIF) from the
mitochondrial intermembrane space in the cytoplasm,
resulting in downstream activation of caspase-9 [18,19].
Regardless of the stimuli origin both pathways culmin-
ate in the activation of cysteine aspartyl protease 3 (cas-
pase-3), caspase-6 and caspase-7, which results in
chromatin condensation and DNA fragmentation.
Following the binding of TNF to its death receptor
TNFR1, and subsequent recruitment of the TNF-
associated death domain (TRADD) adapter protein, two
events can occur: (i) activation of pro-inflammatory and
potentially pro-tumor survival pathways through NF-κB,
JNK and p38 or (ii) induction of apoptotic cell death via
recruitment of Fas-associated death domain (FADD) and
caspase-8 activation, culminating in the activation of
caspase-3 [20,21]. Thus, death receptor signaling, despite
its name, can either induce cell death by apoptosis or acti-
vate non-apoptotic cell signaling pathways.
Although some studies have linked the occurrence of T
lymphocyte apoptosis with high levels of soluble Fas lig-
and (sFasL) in human malaria, the involvement of the Fas/
FasL system has not been observed in experimental
models of malaria [10,22]. Thus, unlike the studies that
suggest the involvement of Fas/FasL in the lymphocyto-
paenia observed in patients with P. falciparum malaria, no
increased expression of Fas and FasL genes in the CD4+ T
lymphocytes of patients with P. vivax malaria was ob-
served, similar to what had been found in malaria mouse
models. In these experimental studies, apoptosis of
Plasmodium-specific CD4+ T cells was associated with
IFN-γ. In a mouse model of malaria using P. berghei,
the parasite ortholog of macrophage migration inhibi-
tory factor (PMIF) induced the upregulation of T-bet
and IFN-γ and the downregulation of IL-7R, IL-7, IL-2
and Bcl-2 in T cells specific for the parasite [22]. These
CD4+ T cells showed increased susceptibility to
Hojo-Souza et al. Malaria Journal 2015, 14:5 Page 6 of 7
http://www.malariajournal.com/content/14/1/5apoptosis and were associated with low expression of
Bcl-2, but not with Fas/FasL signaling. Importantly, pa-
tients with P. falciparum cerebral malaria also had
higher levels of serum PMIF compared with patients
with uncomplicated malaria [22].
The results demonstrate that CD4+ T lymphocytes from
patients infected with P. vivax malaria have increased ex-
pression of TNFR1 and Bid and decreased expression of
anti-apoptotic Bcl-2 mRNA. Bcl-2 is an anti-apoptotic
protein that exerts its action through interaction with pro-
apoptotic proteins such as Bcl-2 associated X-protein
(Bax) and Bcl-2 homologous antagonist killer (Bak), inhi-
biting their activity. Moreover, Bid is a pro-apoptotic pro-
tein that exerts its action directly activating Bax/Bak,
culminating in cell apoptosis. Therefore, the reduction in
the expression of Bcl-2 and the increase in the expression
of Bid may lead to increased pro-apoptotic signaling in ac-
tivated CD4+ T cells [23]. A signaling amplification loop is
activated when caspase-8 levels are insufficient to activate
caspase-3. Under these circumstances, caspase-8 cleaves
Bid, yielding tBid (truncated Bid), which translocates to
the mitochondria and directly activates Bax/Bad for pore
formation, increasing the permeability of the mitochon-
drial outer membrane and culminating in apoptosis
[20,21,23].
Apoptosis signaling pathways can be categorized into
two types: (i) type I, mediated by TNFR1, with activation
of caspase-3 by caspase-8 or by tBid, and (ii) type II, reg-
ulated by anti-apoptotic Bcl-2 proteins, which inhibit the
function of pro-apoptotic proteins (such as Bax and
Bad) to block apoptosis mediated by tBid or XIAP pro-
tein (inhibitor of caspase-9 activation – BIRC 4) [21].
Another important death receptor expressed on the cell
surface is TNFRSF25 (also known as DR3), which is acti-
vated by TL1A [20].
The results showed that P. vivax-infected donors dis-
played decreased expression of TNFRSF25, suggesting
that this gene is not involved in the apoptosis induced
by P. vivax. Similar result was observed with CD40L, in-
dicating no activation of CD40 signaling.
In addition to apoptosis activated by death receptors
(extrinsic pathway) and mitochondria (intrinsic path-
way), an alternative way to induce apoptosis has been
proposed involving a protein called PIDD (p53-induced
protein with death domain). This pathway, named PID-
Dosome, has been implicated in p53-dependent activa-
tion of caspase-2 in response to genotoxic stress [19].
The results showed a reduction in the gene expression
of p53 and caspase-2 in malaria-infected individuals,
suggesting that this pathway is not involved in P. vivax-
induced apoptosis.
In the present study, it was observed a significant re-
duction in the gene expression of BIRC 2, 3 and 6 in P.
vivax-infected donors, suggesting that these inhibitors ofapoptotic proteins are not inhibiting the caspase path-
way, thus contributing to apoptosis. The IAPs are an im-
portant group composed of eight proteins (BIRC 1–8)
with anti-apoptotic roles involved in the caspase path-
way. The BIRC family can be divided into two groups:
BIRCs that act directly on caspases (BIRC 1–4, 7 and 8)
and BIRCs that act in mitotic spindle formation (BIRC 5
and 6) [24]. On the other hand, pro-apoptotic molecules
released from mitochondria (Smac/DIABLO and Omi/
HtrA2) are capable of neutralize IAPs binding in BIRC
2, 3, 4, 5 or 6 through IAP-binding motif presents in the
their N-terminal region [18].
Finally, it was detected an increase in the plasma levels
of TNF in P. vivax-infected donors in comparison with
malaria-naive donors. This finding is consistent with
prior studies that have shown higher levels of TNF in
the plasma of individuals infected by P. vivax [9,25,26]
and suggest that P. vivax-infected individuals, which
present with elevated plasma levels of TNF and in-
creased expression of TNFR1, might likely have in-
creased activation of the apoptosis cascade via the TNF
pathway. Taken together, the results indicate that in-
creased CD4+ T lymphocyte apoptosis during P. vivax
malaria is mediated by either up-regulation of the
TNFR1 pathway involving the Bid amplification loop
(type I) and down-regulation of anti-apoptotic Bcl-2 sig-
naling (type II). While T lymphocyte apoptosis might en-
able parasite persistence by limiting the occurrence of
immunopathology, further studies are still required to
determine whether this mechanism reflects a homeo-
static host response against the presence of the parasite
or whether it might reflect an immune evasion strategy
triggered by the parasite.
Additional files
Additional file 1: Flow cytometric analysis of apoptosis of CD4+ T cells.
Percentage of non-CD4 T cells (A), monocytes (B) and granulocytes (C) in early
and late apoptosis from malaria-naive donors and P. vivax-infected donors.
Mann–Whitney test was used for comparison. Bars represent the median.
Additional file 2: Enrichment of T CD4+ lymphocytes from PBMCs.
Representative example of gating strategy used to characterize CD4+ T cells
after enrichment by magnetic activated cell sorting. In the left panel, flow
cytometry pattern (FSC x SSC) of PBMCs. In the right panel, proportion of T
CD4+ cell in regular PBMCs, after cell separation and in the CD4-depleted
fraction. Data were collected on 1x105 lymphocytes (gated by forward and
side scatter) and analysed using Flow Jo software (Tree Star Inc., USA).
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